Although there were few differences in gene expression in surviving cancer cells after Pembrolizumab treatment, PDS cultures not-responding to the treatment had significantly higher SOX2 and lower MKI67 expression compared to responding PDS cultures (Fig. 5e, f, Supplementary Fig. 8b, Supplementary Table 12). The gene discussed is SOX2; the disease is cancer.